Cost-effectiveness analysis of a fixed-dose combination of indacaterol and glycopyrronium as maintenance treatment for COPD

OBJECTIVE: The aim of this study was to evaluate the cost-effectiveness of the long-acting beta-2 agonist (LABA)/long-acting muscarinic antagonist (LAMA) dual bronchodilator indacaterol/glycopyrronium (IND/GLY) as a maintenance treatment for COPD patients from the perspective of health care payer in...

Full description

Saved in:
Bibliographic Details
Published in:Int J Chron Obstruct Pulmon Dis
Main Authors: Chan, Ming-Cheng, Tan, Elise Chia-Hui, Yang, Ming-Chin
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2018
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5894684/
https://ncbi.nlm.nih.gov/pubmed/29670344
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S159103
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items